| 1A2Q | A: | SUBTILISIN BPN' MUTANT 7186 |
| 1AK9 | A: | SUBTILISIN MUTANT 8321 |
| 1AQN | A: | SUBTILISIN MUTANT 8324 |
| 1AU9 | A: | SUBTILISIN BPN' MUTANT 8324 IN CITRATE |
| 1DUI | A: | SUBTILISIN BPN' FROM BACILLUS AMYLOLIQUEFACIENS, CRYSTAL GROWTH MUTANT |
| 1GNS | A: | SUBTILISIN BPN' |
| 1GNV | A: | CALCIUM INDEPENDENT SUBTILISIN BPN' MUTANT |
| 1LW6 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 AT 1.5 ANGSTROM RESOLUTION |
| 1S01 | A: | LARGE INCREASES IN GENERAL STABILITY FOR SUBTILISIN BPN(PRIME) THROUGH INCREMENTAL CHANGES IN THE FREE ENERGY OF UNFOLDING |
| 1S02 | A: | EFFECTS OF ENGINEERED SALT BRIDGES ON THE STABILITY OF SUBTILISIN BPN' |
| 1SBH | A: | SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) MUTANT (M50F, N76D, G169A, Q206C, N218S, K256Y) |
| 1SBI | A: | SUBTILISIN BPN' 8397 (E.C. 3.4.21.14) MUTANT (M50F, N76D, G169A, Q206C, N218S) |
| 1SBN | E: | REFINED CRYSTAL STRUCTURES OF SUBTILISIN NOVO IN COMPLEX WITH WILD-TYPE AND TWO MUTANT EGLINS. COMPARISON WITH OTHER SERINE PROTEINASE INHIBITOR COMPLEXES |
| 1SBT | A: | ATOMIC COORDINATES FOR SUBTILISIN BPN (OR NOVO) |
| 1SIB | E: | REFINED CRYSTAL STRUCTURES OF SUBTILISIN NOVO IN COMPLEX WITH WILD-TYPE AND TWO MUTANT EGLINS. COMPARISON WITH OTHER SERINE PROTEINASE INHIBITOR COMPLEXES |
| 1SPB | S: | SUBTILISIN BPN' PROSEGMENT (77 RESIDUES) COMPLEXED WITH A MUTANT SUBTILISIN BPN' (266 RESIDUES). CRYSTAL PH 4.6. CRYSTALLIZATION TEMPERATURE 20 C DIFFRACTION TEMPERATURE-160 C |
| 1ST2 | A: | THE THREE-DIMENSIONAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS SUBTILISIN AT 1.8 ANGSTROMS AND AN ANALYSIS OF THE STRUCTURAL CONSEQUENCES OF PEROXIDE INACTIVATION |
| 1SUA | A: | SUBTILISIN BPN' |
| 1SUB | A: | CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN |
| 1SUC | A: | CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN |
| 1SUD | A: | CALCIUM-INDEPENDENT SUBTILISIN BY DESIGN |
| 1SUE | A: | SUBTILISIN BPN' FROM BACILLUS AMYLOLIQUEFACIENS, MUTANT |
| 1SUP | A: | SUBTILISIN BPN' AT 1.6 ANGSTROMS RESOLUTION: ANALYSIS OF DISCRETE DISORDER AND COMPARISON OF CRYSTAL FORMS |
| 1TM1 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 |
| 1TM3 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59K MUTANT |
| 1TM4 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILSIN BPN'WITH CHYMOTRYPSIN INHIBITOR 2 M59G MUTANT |
| 1TM5 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59A MUTANT |
| 1TM7 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59Y MUTANT |
| 1TMG | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59F MUTANT |
| 1TO1 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 Y61A MUTANT |
| 1TO2 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59K, IN PH 9 CRYOSOAK |
| 1UBN | A: | SELENOSUBTILISIN BPN |
| 1Y1K | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 T58A MUTANT |
| 1Y33 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 T58P MUTANT |
| 1Y34 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 E60A MUTANT |
| 1Y3B | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 E60S MUTANT |
| 1Y3C | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 R62A MUTANT |
| 1Y3D | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 R67A MUTANT |
| 1Y3F | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 F69A MUTANT |
| 1Y48 | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 R65A MUTANT |
| 1Y4A | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59R/E60S MUTANT |
| 1Y4D | E: | CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' WITH CHYMOTRYPSIN INHIBITOR 2 M59R/E60S MUTANT |
| 1YJA | A: | SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 20% DIMETHYLFORMAMIDE |
| 1YJB | A: | SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 35% DIMETHYLFORMAMIDE |
| 1YJC | A: | SUBTILISIN BPN' 8397+1 (E.C. 3.4.21.14) (MUTANT WITH MET 50 REPLACED BY PHE, ASN 76 REPLACED BY ASP, GLY 169 REPLACED BY ALA, GLN 206 REPLACED BY CYS, ASN 218 REPLACED BY SER AND LYS 256 REPLACED BY TYR) (M50F, N76D, G169A, Q206C, N218S, AND K256Y) IN 50% DIMETHYLFORMAMIDE |
| 2SBT | A: | A COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF SUBTILISIN BPN AND SUBTILISIN NOVO |
| 2SIC | E: | REFINED CRYSTAL STRUCTURE OF THE COMPLEX OF SUBTILISIN BPN' AND STREPTOMYCES SUBTILISIN INHIBITOR AT 1.8 ANGSTROMS RESOLUTION |
| 2SNI | E: | STRUCTURAL COMPARISON OF TWO SERINE PROTEINASE-PROTEIN INHIBITOR COMPLEXES. EGLIN-C-SUBTILISIN CARLSBERG AND CI-2-SUBTILISIN NOVO |
| 2ST1 | A: | THE THREE-DIMENSIONAL STRUCTURE OF BACILLUS AMYLOLIQUEFACIENS SUBTILISIN AT 1.8 ANGSTROMS AND AN ANALYSIS OF THE STRUCTURAL CONSEQUENCES OF PEROXIDE INACTIVATION |
| 3BGO | S: | AZIDE COMPLEX OF ENGINEERED SUBTILISIN SUBT_BACAM |
| 3CNQ | S: | PROSUBTILISIN SUBSTRATE COMPLEX OF SUBTILISIN SUBT_BACAM |
| 3CO0 | S: | SUBSTRATE COMPLEX OF FLUORIDE-SENSITIVE ENGINEERED SUBTILISIN SUBT_BACAM |
| 3SIC | E: | MOLECULAR RECOGNITION AT THE ACTIVE SITE OF SUBTILISIN BPN': CRYSTALLOGRAPHIC STUDIES USING GENETICALLY ENGINEERED PROTEINACEOUS INHIBITOR SSI (STREPTOMYCES SUBTILISIN INHIBITOR) |
| 5SIC | E: | MOLECULAR RECOGNITION AT THE ACTIVE SITE OF SUBTILISIN BPN': CRYSTALLOGRAPHIC STUDIES USING GENETICALLY ENGINEERED PROTEINACEOUS INHIBITOR SSI (STREPTOMYCES SUBTILISIN INHIBITOR) |
)
)